Images of slides scanned on different digital pathology platforms prepared using a range of staining protocols
Developed from rich datasets extracted from over 10 million slides from pathology institutes around the world, Ibex’s technology was designed from the ground up by pathologists to empower pathologists. Our AI-powered diagnostic platform leverages:
Millions of pathology reports and medical records spanning decades of longitudinal patient data
Algorithms trained by a diverse, global team of senior pathologists that have marked and labelled slides using more than 150,000 image annotations
Rigorous deep learning techniques applied by a team of software developers and data scientists to enable clinical-grade applications
With the broadest artificial intelligence technology in the field, Ibex helps diagnose cancer (including rare sub-types), grade different malignancies and detect more than a hundred other clinically relevant diagnostic features in multiple tissue types. Ibex technology supports pathologists in their everyday practice and delivers unparalleled benefits to patients, health systems and diagnostics providers.
Multiple solutions under the Ibex platform are CE marked (IVDD) and registered with the UK MHRA and ANVISA in Brazil. The First Read application for prostate is also CE marked under IVDR. The Ibex AI platform includes solutions which are for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.